⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
IBIO News
iBio, Inc. Common Stock
Breakthrough Immorta Bio Study Collaboration With TAM Global Increases Life Span In Mice over 70% Using Novel Combination Senolytics
prnewswire.com
IBIO
iBio to Participate in Upcoming Healthcare Investor Conferences
globenewswire.com
IBIO
iBio Becomes a Clinical-Stage Company with First Participant Dosed in Phase 1 Clinical Trial of IBIO-600 in Adults with Obesity
globenewswire.com
IBIO
InduPro Therapeutics Appoints Amanda J. Redig, MD, PhD, as Chief Medical Officer
businesswire.com
IBIO
Scientific Longevity Company Immorta Bio Appoints Former Ernst & Young Health Sciences Partner Howard Brooks to Corporate Board of Directors
prnewswire.com
IBIO
Form 8-K
sec.gov
IBIO
iBio Reports Q3 Fiscal Year 2026 Financial Results and Provides Corporate Update
globenewswire.com
IBIO
Form 8-K
sec.gov
IBIO
iBio Appoints Distinguished Biotech Leader, Elizabeth Stoner, to its Board of Directors
globenewswire.com
IBIO
Global Stem Cell Therapy Market Set to Flourish at a CAGR of ~11% by 2034 Owing to the Technological Advancements and Favorable Regulations | DelveInsight
globenewswire.com
ADAG
ABBV
BIIB
BMRN
BLRX
CNSP
CYCN
GEN
GILD
GRAF
GSK
HSIC
HUBS
IBIO
INCY
JAZZ
JNJ
MAGN
MARA
MRK
NVS
OMER
PFE
PRGS
REGN
RGNX
SRPT
TENB
TGLS
TGTX
TNDM
TXG
VRTX